For citations:
Menshikov K.V., Sultanbaev A.V., Musin Sh.I., Menshikova I.A., Sultanbaeva N.I., Izmailov A.A., Fatikhova A.A., Lipatov D.O., Serebrennikov G.A. Possible applications for combined lenvatinib and pembrolizumab in advanced endometrial carcinoma. Creative surgery and oncology. 2022;12(4):309-319. (In Russ.) https://doi.org/10.24060/2076-3093-2022-12-4-309-319
Email this article 